Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management.
Saved in:
| Title: | Study Design and Baseline Characteristics of the VERINA Study: Phase IV Evidence of Vericiguat for Worsening Heart Failure Management. |
|---|---|
| Authors: | Abdulakutty, Jabir1 (AUTHOR) drjabi@yahoo.co.in, Abhyankar, Atul2 (AUTHOR), Seth, Sandeep3 (AUTHOR), Sharma, Kamal4 (AUTHOR), Aggarwal, Rakesh Kumar5 (AUTHOR), Bhalani, Nirav6 (AUTHOR), Vijan, Vinod7 (AUTHOR), Bansal, Sandeep8 (AUTHOR), Jain, Rajendra Kumar Premchand9 (AUTHOR), Banerjee, Suvro10 (AUTHOR), Chopra, V. K.11 (AUTHOR), Oomman, Abraham12 (AUTHOR), Kahale, Pravin13 (AUTHOR), Sodhi, Priyanka14 (AUTHOR), Gawde, Ashish14 (AUTHOR) |
| Source: | Cardiology & Therapy. Mar2026, Vol. 15 Issue 1, p83-99. 17p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!